Verification Pending — official Grants.gov candidate (posted)
RFA-AI-28-024
Accelerating Research and Development of Next Generation Vaccines against Malaria – a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Official Grants.gov opportunity RFA-AI-28-024 from National Institutes of Health. Requires full eligibility, amount, controlling deadline, award-type and duplication QA before publication.
FundingApplicant-level ceiling not stated in the retrieved federal synopsis; verify in full NOFO.
Deadline2027-02-11 (official deadline clock time and time zone must be checked in NOFO)
Last verifiedAtlas review
Required next actionReview the official full announcement, amendments and submission portal requirements before applying.
Broad Eligibility
Native American tribal organizations (other than Federally recognized tribal governments); County governments; Special district governments; Native American tribal governments (Federally recognized); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public and State controlled institutions of higher education; Small businesses; City or township governments; Private institutions of higher education; For profit organizations other than small businesses; State governments; Independent school districts
Official funding announcement — preliminary draft
Funder: National Institutes of Health
Opportunity number: RFA-AI-28-024
Official listed status: posted
Closing information: 2027-02-11 (official deadline clock time and time zone must be checked in NOFO)
Award disclosure: Applicant-level ceiling not stated in the retrieved federal synopsis; verify in full NOFO.
Applicant categories in federal synopsis: Native American tribal organizations (other than Federally recognized tribal governments); County governments; Special district governments; Native American tribal governments (Federally recognized); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public and State controlled institutions of higher education; Small businesses; City or township governments; Private institutions of higher education; For profit organizations other than small businesses; State governments; Independent school districts
Federal synopsis
The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria – one of the deadliest mosquito-borne diseases – by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.
Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.
Official Grants.gov opportunity and NOFO
From Funding to Implementation · School Health Solution
Turn school-health funding into a clinically capable care model.
Dr. Miltie N9+ can support clinician-directed remote exams in school settings, helping care teams move beyond video-only encounters when a funded program calls for stronger pediatric access.
Source verificationOfficial government source · www.grants.govAtlas last verified this record during its latest review. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
